| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2026-01-08 | Chou William | PRESIDENT AND CEO | Sale+OE | 4,076 | $18.44 | $75,158.99 | -38.5% | → |
| 2026-01-08 | Borthwick Kathleen | CFO | Sale+OE | 2,062 | $18.44 | $38,022.04 | -27.6% | → |
| 2025-09-15 | Lynx1 Capital Management LP | - | Buy | 32,008 | $6.99 | $223,734.68 | +1.8% | → |
| 2025-07-24 | Lynx1 Capital Management LP | - | Buy | 128,848 | $5.70 | $733,825.53 | +8.8% | → |
| 2025-06-26 | ORBIMED ADVISORS LLC | - | Sell | 583,657 | $0.34 | $197,238.81 | -3.0% | → |
| 2025-04-24 | ORBIMED ADVISORS LLC | - | Sell | 235,572 | $0.33 | $78,730.58 | -1.2% | → |
| 2025-04-17 | ORBIMED ADVISORS LLC | - | Sell | 149,054 | $0.33 | $49,704.12 | -0.7% | → |
| 2025-02-11 | Borthwick Kathleen | CFO | Sale+OE | 3,183 | $0.53 | $1,685.72 | -7.2% | → |
| 2025-01-14 | ORBIMED ADVISORS LLC | - | Sell | 223,219 | $0.64 | $142,223.38 | -1.0% | → |
| 2025-01-08 | ORBIMED ADVISORS LLC | - | Sell | 147,024 | $0.70 | $103,305.69 | -0.7% | → |
| 2024-12-27 | Lynx1 Capital Management LP | - | Buy | 373,645 | $0.65 | $241,038.39 | +4.2% | → |
| 2024-12-20 | ORBIMED ADVISORS LLC | - | Sell | 230,321 | $0.60 | $138,192.60 | -3.0% | → |
| 2024-12-11 | ORBIMED ADVISORS LLC | - | Sell | 62,276 | $0.83 | $51,988.04 | -0.3% | → |
| 2024-12-06 | ORBIMED ADVISORS LLC | - | Sell | 97,103 | $0.80 | $77,338.46 | -0.6% | → |
| 2024-11-27 | Lynx1 Capital Management LP | - | Buy | 456,353 | $0.62 | $284,519.51 | +1.8% | → |
| 2024-09-19 | ORBIMED ADVISORS LLC | - | Sell | 39,300 | $0.71 | $27,903.00 | -0.5% | → |
| 2024-09-18 | ORBIMED ADVISORS LLC | - | Sell | 200,131 | $0.73 | $146,726.63 | -0.8% | → |
| 2024-02-13 | Borthwick Kathleen | SVP, INTERIM CFO | Sale+OE | 1,470 | $0.97 | $1,425.90 | -4.9% | → |
| 2024-02-13 | Forman Mark S | CHIEF MEDICAL OFFICER | Sale+OE | 1,638 | $0.97 | $1,588.86 | -3.3% | → |
| 2024-01-02 | Forman Mark S | Chief Medical Officer | Sale+OE | 15,813 | $0.91 | $14,389.83 | -25.9% | → |
| 2024-01-02 | Borthwick Kathleen | SVP, Interim CFO | Sale+OE | 10,672 | $0.91 | $9,711.52 | -29.2% | → |
| 2024-01-02 | Cale Edgar B. | GC & Corporate Secretary | Sale+OE | 15,813 | $0.91 | $14,389.83 | -25.6% | → |
| 2023-07-28 | King Simona | Chief Financial Officer | Sale+OE | 11,453 | $0.88 | $10,078.64 | -32.3% | → |
| 2023-06-28 | ORBIMED ADVISORS LLC | - | Buy | 1,192,577 | $0.84 | $1,001,764.68 | +8.3% | → |
| 2023-06-16 | Fotopoulos Alexandros | Chief Technical Officer | Sale+OE | 4,052 | $0.93 | $3,778.49 | -12.4% | → |
| 2023-04-18 | King Simona | Chief Financial Officer | Sale+OE | 2,053 | $1.05 | $2,155.65 | -50.0% | → |
| 2022-12-01 | Kapadia Sandip | - | Sell | 5,000 | $1.19 | $5,964.50 | -100% | → |
| 2022-11-22 | Fotopoulos Alexandros | Chief Technical Officer | Sale+OE | 3,720 | $1.33 | $4,947.60 | -15.5% | → |